Mobic and Aranesp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mobic (meloxicam) and Aranesp (darbepoetin alfa). Common drug interactions include tooth loss among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Mobic and Aranesp. It is created by eHealthMe based on reports of 67 people who take the same drugs from the FDA, and is updated regularly.

What is Mobic?

Mobic has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 26,684 Mobic users. Check the latest studies of Mobic.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.



On Jul, 31, 2026

67 people who take Mobic and Aranesp together, and have interactions are studied.

Mobic and Aranesp drug interactions.

What are the common drug interactions of Mobic and Aranesp, by gender? *:

female:

  1. Tooth loss
  2. Polyuria (production of too much dilute urine)
  3. Spinal osteoarthritis (joint cartilage loss in spine)
  4. Fatigue (feeling of tiredness)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Anaemia (lack of blood)
  7. Tooth extraction
  8. Muscular weakness (muscle weakness)
  9. Back pain
  10. Pruritus (severe itching of the skin)

male:

  1. Anaemia (lack of blood)
  2. Multiple myeloma (cancer of the plasma cells)
  3. Bone disorder
  4. Breast mass
  5. Calculus ureteric (stone in ureter)
  6. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  7. Costochondritis (chest wall pain)
  8. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  9. Dental caries
  10. Disability

What are the common drug interactions of Mobic and Aranesp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  3. Anaemia of chronic disease
  4. Anaphylactic reaction (serious allergic reaction)
  5. Angina pectoris (chest pain due to ischemia of the heart muscle)
  6. Angioedema (rapid swelling of the dermis)
  7. Anxiety
  8. Arrhythmia (irregular heartbeat)
  9. Arteritis (inflammation of the walls of arteries)
  10. Arthropathy

30-39:

n/a

40-49:

  1. Renal failure (kidney dysfunction)
  2. Dyspnoea (difficult or laboured respiration)
  3. Abdominal pain
  4. Anaemia (lack of blood)
  5. Angiopathy (generic term for a disease of the blood vessels)
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Back pain
  9. Bacteraemia (presence of bacteria in the blood)
  10. Blood cholesterol increased

50-59:

  1. Bone disorder
  2. Bone erosion
  3. Bone fragmentation
  4. Cardiac failure congestive
  5. Congestive cardiomyopathy (weakening of heart muscle)
  6. Constipation
  7. Cough
  8. Deformity (disfigurement)
  9. Dental fistula
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

60+:

  1. Pyrexia (fever)
  2. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  3. Osteomyelitis (infection of bone)
  4. Pain in jaw
  5. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  6. Hypotension (abnormally low blood pressure)
  7. Infection
  8. Abdominal pain
  9. Tooth extraction
  10. Back pain

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 43 people, 64.18%
  2. High Blood Pressure: 17 people, 25.37%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 17 people, 25.37%
  4. Fatigue (feeling of tiredness): 16 people, 23.88%
  5. Stress And Anxiety: 14 people, 20.90%
  6. Pain In Jaw: 14 people, 20.90%
  7. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 5 people, 7.46%
  8. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 4 people, 5.97%
  9. Pain: 4 people, 5.97%

* Approximation only. Some reports may have incomplete information.

Do you take Mobic and Aranesp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mobic and Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mobic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mobic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aranesp and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and darbepoetin alfa (the active ingredients of Mobic and Aranesp, respectively), and Mobic and Aranesp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: